Effect of cyclosporin on dry eye treatment

Phase 2

• Conditions: Dry Eye.; Other disorders of lacrimal gland

• Registration Number: IRCT2016093030059N1
• Lead Sponsor: Vice-chancellor for Research, Birjand University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 February 2018

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 30

Inclusion Criteria

All visitors to the ophthalmology clinic of Valiasr Hospital of Birjand with clinical and paraclinical signs of dry eye; willingness to participate in the study; Non-occurrence of blindness in or conjunctivitis of one eye or both eyes; absence of foreign body in the eye; non-closure of the eye because of recent surgery, or non-occurrence of dry eye after trauma or burning; Exclusion criteria: unwillingness to continue the study

Exclusion Criteria

Not provided

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Dry eyes. Timepoint: Before intervention, one week, one month, and three months after intervention. Method of measurement: Schirmer's test; SPEED scale.;Feeling of sand in the eyes. Timepoint: Before intervention, one week, one month, and three months after intervention. Method of measurement: Schirmer's test; SPEED scale.;Itching. Timepoint: Before intervention, one week, one month, and three months after intervention. Method of measurement: Schirmer's test; SPEED scale.;Pain and burning eyes. Timepoint: Before intervention, one week, one month, and three months after intervention. Method of measurement: Schirmer's test; SPEED scale.;Watery eye. Timepoint: Before intervention, one week, one month, and three months after intervention. Method of measurement: Schirmer's test; SPEED scale.;Eye fatigue. Timepoint: Before intervention, one week, one month, and three months after intervention. Method of measurement: Schirmer's test; SPEED scale.